Wegovy Price Drop: What UK Patients Are Actually Seeing in 2025–2026

You searched for a price drop. Here's what's actually moved, and what hasn't

Picture this: you've been on Wegovy for a few months, things are working, and someone in a Facebook group mentions they've seen it cheaper elsewhere. You start Googling. The results are a mix of outdated figures, US pricing (which bears no relation to UK costs), and a few providers quoting very low entry prices that don't mention what's included.

So let's be precise. Wegovy's UK private pricing is set by individual pharmacies and clinics, not by a fixed manufacturer retail price, which means what you pay genuinely does vary. Novo Nordisk, Wegovy's manufacturer, has not announced a UK price reduction equivalent to the Mounjaro list-price change of September 2025 that many readers will have seen reported. If you've seen headlines about a "Wegovy price drop UK," they typically refer either to specific providers adjusting their own margins or to US market changes that do not apply here, and our dedicated page on the 2026 Wegovy price drop sets out exactly what has and hasn't changed. The full picture of Wegovy pricing in the UK is worth reading before you draw conclusions from a headline figure.

At the lower-dose end of treatment, monthly costs are naturally lower, the 0.25mg and 0.5mg starting doses cost less than the 1.7mg or 2.4mg maintenance doses. That can look like a "price drop" when someone quotes their first month's cost. It isn't. It's the titration schedule. You can find more on how dose affects cost on our dose-specific pricing page.

What a headline Wegovy price often leaves out

You've found a quote that looks lower than expected. Before you act on it, run through the extras that sometimes appear at checkout or not at all.

Consultation and assessment fees are sometimes charged separately. A private prescription from a registered prescriber has a cost, and some providers itemise it while others roll it in. Delivery (especially tracked, temperature-controlled delivery for a medication that needs to stay refrigerated) adds to the real cost if it isn't included. Aftercare and clinical support between doses varies widely: some providers offer it, some don't, and finding out after you've started treatment is an uncomfortable moment.

When you compare Wegovy prices across providers, the only fair comparison is the total monthly spend for treatment, prescription, delivery and clinical support combined. A figure that only covers the pen itself is incomplete, and our breakdown of what the Wegovy pen price actually includes helps you see what to look for when comparing quotes. Our Wegovy cost breakdown page goes through each component honestly.

For completeness: the current 7.2mg single-dose pen, approved by the MHRA in April 2026 as detailed in the GOV.UK announcement, means the dose range has expanded, and with it the cost range. Availability of specific pen formats is confirmed at consultation, not before.

What nume includes, and why we're not trying to be the cheapest

When you order from nume, one price covers your consultation, prescription, treatment, and next-working-day delivery. There are no hidden fees at checkout. Your DPD tracking notification arrives, a plain unbranded box shows up, and inside is your pen, handled through the licensed UK supply chain and dispensed from our GPhC-registered pharmacy (registration number 9012878, verifiable on the GPhC register).

We don't run discount codes, promotional offers or seasonal sales. We won't. Wegovy is a prescription medicine, and attaching vouchers to it sits badly with how we think prescribing should work. What we offer instead is a service that doesn't make you shop around for what's included: seven-day aftercare, same-day clinical review by a named GPhC-registered Independent Prescriber (a real clinician reads your answers, not software), and free repeat consultation before every subsequent order.

We're not the cheapest. That's a deliberate position. A team, a pharmacy, a prescribing standard and next-day tracked delivery cost money, and cutting corners on any of those is where patients end up worse off. You can read more about how we work on our about page or explore our clinical team through our lead prescriber's profile.

For a prescription medicine, 'cheapest' answers the wrong question

The MHRA has been clear about the risks of seeking out bargain prices for GLP-1 medicines. Counterfeit semaglutide pens have been seized in the UK in large quantities, and some fake pens have been found to contain insulin, a dangerous substitution that has led to hospitalisations. The regulator's Yellow Card scheme allows patients to report both suspected side effects and suspect sellers.

The red flags are consistent: sellers offering Wegovy without a prescription, prices substantially below the market range, social-media storefronts, and discount codes from unknown sources. A provider offering Wegovy cheaply without explaining how the prescription process works is not offering you a better deal, it's offering you a different kind of risk.

Clinical supervision matters throughout treatment, not just at the start. Your dose is titrated over months, and how you respond at each level should be reviewed by a prescriber who knows your case. That ongoing relationship is part of what legitimate treatment costs. Browse our full Wegovy information page for the clinical context, or take a look at our weight-loss treatment overview if you're still deciding which medicine fits your situation.

When you're ready to have your eligibility assessed properly, start your free consultation, a prescriber will review your answers the same day.